Indication

Pneumococcus endocarditis

Pneumococcus endocarditis is a severe, acute form of infective endocarditis caused by the bacterium *Streptococcus pneumoniae*. Read more about Pneumococcus endocarditis

15 drugs 12 manufacturers

Advertisement

Drugs that treat it

Common Pneumococcus endocarditis therapies.

Showing 10–15 of 15 drugs

Filter & compare in the drug finder →Opens the drug finder with Pneumococcus endocarditis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Pneumococcus endocarditis.

Pneumococcus endocarditis is a severe, acute form of infective endocarditis caused by the bacterium *Streptococcus pneumoniae*.

It affects the cardiovascular system, primarily seeding native cardiac valves—most frequently the aortic valve—and disproportionately impacts adults with history of alcohol use disorder, asplenia, chronic pulmonary disease, or immunocompromising states.

Pathophysiologically, the organism causes rapid, aggressive endothelial and valvular destruction, often leading to acute regurgitation, perivalvular abscess formation, and congestive heart failure.

Clinically, it frequently arises secondary to invasive bacteremia from a primary respiratory focus and may present alongside pneumonia and purulent meningitis, a triad classically recognized as Austrian syndrome.

Personalize your experience

Follow Pneumococcus endocarditis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it